s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filed
Friday, September 2, 2022
Accession number
0000950123-22-009778
Documents
filename1.htm
DRS/A
On sec.gov
Filing index
All files
Complete submission text
SGML header